Lincocin

Pays: Nouvelle-Zélande

Langue: anglais

Source: Medsafe (Medicines Safety Authority)

Ingrédients actifs:

Lincomycin hydrochloride monohydrate equivalent to 250 mg lincomycin base;  

Disponible depuis:

Pharmacia Limited Company trading as Pharmacia

DCI (Dénomination commune internationale):

Lincomycin hydrochloride monohydrate (=250 mg lincomycin base)

Dosage:

250 mg

forme pharmaceutique:

Capsule

Composition:

Active: Lincomycin hydrochloride monohydrate equivalent to 250 mg lincomycin base   Excipient: Lactose monohydrate Magnesium stearate Purified talc

Unités en paquet:

Bottle, plastic, 1x24, 24 capsules

classe:

Prescription

Type d'ordonnance:

Prescription

Fabriqué par:

Pfizer Pharmaceuticals LLC

indications thérapeutiques:

indicated in the treatment of upper respiratory infections including tonsillitis, pharyngitis, otitis media, sinusitis, scarlet fever and as adjuvant therapy for diphtheria. Effectiveness in the treatment of mastoiditis would be anticipated.

Descriptif du produit:

Package - Contents - Shelf Life: Bottle, plastic, - 24 capsules - 60 months from date of manufacture stored at or below 25°C - Bottle, plastic, - 100 capsules - 60 months from date of manufacture stored at or below 25°C

Date de l'autorisation:

1969-12-31